FDA approves Novavax COVID-19 shot but with unusual restrictions

[BumRushDaShow]

8. Remember that this vaccine was being developed starting WAY back during the beginning of the pandemic

(during the first term) as one of the "Operation Warp Speed" recipients -

U.S. Will Pay $1.6 Billion to Novavax for Coronavirus Vaccine


By Katie Thomas
Published July 7, 2020 Updated Jan. 28, 2021


The federal government will pay the vaccine maker Novavax $1.6 billion to expedite the development of a coronavirus vaccine. It’s the largest deal to date from Operation Warp Speed, the sprawling federal effort to make coronavirus vaccines and treatments available to the American public as quickly as possible.

The deal would pay for Novavax to produce 100 million doses of its new vaccine by the beginning of next year — if the vaccine is shown to be effective in clinical trials. That’s a significant bet on Novavax, a Maryland company that has never brought a product to market. With this deal, the federal government has now invested nearly $4 billion in companies pursuing vaccines, but has provided little information about how Operation Warp Speed is spending money, which agencies the funding is coming from or how decisions are being made.

That money has gone to six companies with varying track records and, in many cases, promising but untested technologies. British drugmaker AstraZeneca has received $1.2 billion in federal assistance for its vaccine, which uses a harmless virus to provoke an immune response. Moderna Therapeutics, which has received more than $500 million, also has never brought a product to market and is using a genetic technology that is valued for its speed but has never led to a successful human vaccine.

Some say the administration’s strategy — backing a variety of approaches, including some that are cutting-edge but may not work — is the best way to move quickly in the middle of a deadly pandemic. But critics say the public deserves to know more about how taxpayer money is being spent at this critical moment.

(snip)

This was back when Fauci was still there. They were pretty much the "last ones" still running and finally crossed the finish line - several years late. The only others still alive are Pfizer (not part of Operation Warp Speed) & Moderna. J&J's (Janssen) & Astrazeneca's (both using similar platforms) were pulled due to the adverse reactions, and Merck & Sanofi/GSK's attempts were delayed, and then dropped.

This new one is the only "non-mRNA" type of COVID vaccine (to date) approved in the U.S.